A detailed history of Ggm Financials LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ggm Financials LLC holds 745 shares of LLY stock, worth $562,475. This represents 0.57% of its overall portfolio holdings.

Number of Shares
745
Previous 719 3.62%
Holding current value
$562,475
Previous $651 Million 1.38%
% of portfolio
0.57%
Previous 0.6%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $20,075 - $24,960
26 Added 3.62%
745 $660 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $521,181 - $653,599
719 New
719 $651 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ggm Financials LLC Portfolio

Follow Ggm Financials LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ggm Financials LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ggm Financials LLC with notifications on news.